Skip to content

Efficacy of Dry Needling versus Lidocaine Injection for Upper Trapezius Myofascial Pain Syndrome in Buddahasothorn hospital: A Randomized Controlled Trial

Efficacy of Dry Needling versus Lidocaine Injection for Upper Trapezius Myofascial Pain Syndrome in Buddahasothorn hospital: A Randomized Controlled Trial

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260203001
Enrollment
46
Registered
2026-02-03
Start date
2026-02-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial Pain Syndrome (MPS) myofacial pain, muscle pain

Interventions

Treat upper trapezius muscle spasm (MPS) using dry needling, assess pain levels with VAS at 1 , 2 and 3 months after treatment, and evaluate quality of life with EQ-5D-5L. at 3 months after treatment
Experimental Procedure/Surgery,Active Comparator Procedure/Surgery
dry needling,lidocain injection

Sponsors

Buddahasothorn Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. age 18-65 years 2.The patient was diagnosed with Upper Trapezius Muscle MPS, meeting all of Travell & Simons' diagnostic criteria (Major and Minor criteria). 3.There are 1-3 clearly identifiable active trigger points in one side of the upper trapezius muscle. 4. have had chronic pain for more than 3 months but less than 12 months. 5.Applicants must have a pain level of 3 or higher (out of 10) on the Visual Analog Scale (VAS) at the time of selection for the program. 6.They understood and voluntarily participated in the research project, having signed the Informed Consent Form.

Exclusion criteria

Exclusion criteria: 1.Have a history of allergy to local anesthetics in the Lidocaine or Xylocaine group. 2.Have a fear of needles 3.Do you have a blood clotting disorder or are you taking anticoagulant medication? 4.There is a skin infection in the area that will be treated. 5.There are signs or symptoms that indicate cervical radiculopathy or myelopathy (disease of the spinal cord). 6.was diagnosed with fibromyalgia according to the diagnostic criteria of the American College of Rheumatology (ACR). 7.Have you received any injections, acupuncture, or other physical therapy treatments to your shoulder muscles within the past 3 months? 8.pregnant or breastfeeding 9.Individuals with intellectual, cognitive, or psychiatric disabilities that prevent them from cooperating in answering questionnaires or following research procedures.

Design outcomes

Primary

MeasureTime frame
pain 3 months pain score

Secondary

MeasureTime frame
Health-Related Quality of Life 3 months EQ-5D-5L

Countries

Thailand

Contacts

Public ContactWorakan Thienkul

Buddhasothorn Hospital Journal

koolkan56@gmail.com038814357

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026